There are few longitudinal data on nutritional status and body composition of patients undergoing allogeneic hematopoietic cell transplantation (alloHCT). We assessed nutritional status of 105 patients before alloHCT and its course during the early posttransplant period to day þ 30 and day þ 100 via weight history, body mass index (BMI) normalized for gender and age, Subjective Global Assessment, phase angle normalized for gender, age, and BMI, and fat-free and body fat masses. Furthermore, we present a multivariate regression model investigating the impact of factors on body weight. At admission, 23.8% reported significant weight losses (45%) in the previous 6 months, and we noted 31.5% with abnormal age-and sex-adjusted BMI values (p10th, X90th percentiles). BMI decreased significantly (Po0.0001) in both periods by 11% in total, meaning a weight loss of 8.6 ± 5.7 kg. Simultaneously, the patients experienced significant losses (Po0.0001) of both fat-free and body fat masses. Multivariate regression model revealed clinically relevant acute GVHD (parameter estimate 1.43; P ¼ 0.02) and moderate/severe anorexia (parameter estimate 1.07; P ¼ 0.058) as independent factors influencing early weight loss. In conclusion, our results show a significant deterioration in nutritional status during the early post-transplant period. Predominant alloHCT-associated complications such as anorexia and acute GVHD became evident as significant factors influencing nutritional status.
INTRODUCTION
Allogeneic hematopoietic cell transplantation (alloHCT) is a potentially curative treatment in patients with diseases of the blood and bone marrow or certain types of cancer. 1 However, alloHCT is a procedure that can cause many complications ranging from mucositis, infections and GVHD to treatment or progressionrelated mortality. [2] [3] [4] AlloHCT-associated complications and their medical treatments often cause tremendous changes in body composition, especially through disturbed muscle metabolism. 5, 6 Furthermore, under-and overweight patients are at an increased risk for complications, non-relapse mortality and overall survival after alloHCT. [7] [8] [9] [10] To date, few studies have assessed nutritional status before alloHCT, and most of them only recorded body mass index (BMI) as a potential risk factor for survival. [7] [8] [9] [10] Except for one report by Kyle et al. 11 on the development of lean body mass, there were until now no longitudinal data on nutritional status and body composition in the early post-transplant period, although several reports showed that depletion of micronutrients, mainly vitamin D, is common before and after alloHCT. [12] [13] [14] There are now many nutritional parameters available and validated for cancer patients. The phase angle is one of them. It is measured by bioelectrical impedance analysis and reflects cell membrane function 15 and indirectly, the body's muscle mass. 16 It is an established parameter for diagnosing malnutrition, and a useful prognostic marker in many clinical conditions 17 including several types of cancer. [18] [19] [20] [21] The Subjective Global Assessment (SGA) questionnaire according to Detsky et al. 22 is another means of demonstrating the best combination of sensitivity and specificity in identifying complications related to malnutrition, 23 making the SGA questionnaire a validated tool in cancer patients with which to evaluate nutritional status. 24 The main objective of this prospective study was to evaluate the nutritional status in patients before alloHCT and its course during the early post-transplant period until day þ 100 via weight change before admission, BMI normalized for gender and age, the SGA questionnaire, the phase angle normalized for gender, age, and BMI, and height-normalized fat-free mass and body fat mass. To deepen the understanding and develop future preventive and interventional approaches, we also investigated the impact of factors influencing the body weight course during the early posttransplant period.
PATIENTS AND METHODS

Study population
All adult patients with hematological malignancies admitted for alloHCT to our institution at University Medical Centre Freiburg between 2008 and 2010 were eligible to enter this prospective survey. The study protocol was approved by our local Ethics Committee, and all patients provided informed consent. Supportive interventions followed our clinic's internal standards, for example, regular diet counseling, parenteral nutrition when needed and high energy supplements ad libitum, combined with regular mobilization and light physical activities.
Study design and data collection
Nutritional status at admission and on days þ 30 and þ 100 after alloHCT was assessed by measuring body weight, performing bioelectrical impedance analysis and assessing nutritional status classification according to the SGA questionnaire. At admission, we recorded weight changes in the previous 6 months, body height, HCT-Comorbidity Index (HCT-CI) 25 and Karnofsky Performance Status. Moreover, we asked at each time point the actual portion size of food intake (100%, 75%, 50%, p25% of usual size) and relevant discomfort (anorexia, diarrhea, taste disturbance, fatigue) graded as: no (0), mild (1), moderate (2) or severe (3). Oral mucositis classified by the WHO oral toxicity scale 26 and infections as early toxicities and duration of parenteral nutrition were assessed until day þ 30. Maximum grade of acute GVHD (aGVHD) (0-IV) and all further medical data were collected from hospital records.
Adjusted BMI. Considering the age and gender dependencies of BMI, we used current and representative German BMI percentiles to categorize each value as low (o10th percentile), normal (10-90th percentile) or high (490th percentile) according to age-and gender-specific BMI percentiles. 27 Subjective Global Assessment (SGA). The SGA questionnaire is a simple, validated bedside tool for use in cancer patients with which to subjectively evaluate nutritional status, mainly according to weight-loss history, relevant symptoms impairing nutrition intake, and a basic physical examination requiring no equipment. Patients were classified as well nourished (SGA-A), moderately malnourished (SGA-B) and severely malnourished (SGA-C), the SGA questionnaire classification has been shown to be associated to quality of life, length of hospital stay and survival. 28 Standardized phase angle. Bioelectrical impedance analysis is a validated, non-invasive, portable method to estimate body composition with specific algorithms based on the electrical properties of body tissues. 29 Bioelectrical impedance analysis is useful in assessing and monitoring nutritional status. 15, 30 The phase angle, one of the raw data obtained from bioelectrical impedance analysis measurements and therefore independent from the equipment and internal algorithms used, has proved to be a good prognostic, nutritional and membrane cell function marker in various diseases. 18 34 The transformation of phase angle values into standardized values (Z-score) allows us to quantify individual deviations from sex-, age-and BMI-specific population averages and to compare subjects from a heterogeneous group. Furthermore, Norman et al. 16 showed that this standardization clearly enhances the phase angle's predictive power. Our analysis employed a multifrequency device (Body Scout instrument, Fresenius Medical Care, Germany) under standardized conditions. 35 Fat-free mass and body fat mass. To better interpret any BMI changes, we used bioelectrical fat-free mass and body fat mass. This method measures total body water, which is then used in equations to estimate the fat-free mass, and that value is subtracted from fat mass weight estimates. 36 We calculated height-normalized indices, namely the fat-free mass index [fat-free mass (kg) / height (m) 2 ] and body fat mass index [body fat mass (kg) /height (m) 2 ], which are useful when comparing individuals of different heights. 37 Fat-free mass includes at the molecular level total body water, bone and soft tissue minerals, visceral proteins and glycogen. 38 In addition, it is directly related to the resting metabolic rate and plays a crucial role in energy balance and nutritional status. 39 Muscle wasting leads to a depletion of fat-free mass at an early stage without affecting body weight. 40 On the other hand, fat mass is a risk factor for cardiovascular disease and metabolic syndrome. 41 
Statistical analysis
We used IBM SPSS 19 (IBM, NY, USA) and SAS 9.2 (SAS Institute Inc., Cary, NC, USA) software for statistical analysis. Mean and s.d. were used in cases of approximately symmetric distributions, and when useful, min-max as well. Paired t-tests were used to analyze differences over time in continuous variables. To examine the impact of potential influencing factors on the body weight course from days þ 30 until day þ 100, we used linear regression models with change in BMI as the dependent variable. First, univariate models were employed for a preliminary assessment of single factors. Then, a multivariate model was constructed with those variables showing a univariate Po0.1. Results of the linear regression model are presented as parameter estimates for the regression coefficients with accompanying two-sided 95% CIs (confidence intervals). For binary independent variables, the regression coefficient describes the difference in BMI course between two groups.
RESULTS
Patient and transplant characteristics
Admittance and transplant characteristics of 105 consecutive patients are summarized in Table 1 . The 62.9% male and 37.1% female patients had a mean age of 56.1 ± 10.9 (22-76) years. The diagnoses were acute leukemias or other myeloid malignancies (76.2%; AML, MDS (myelodysplastic syndrome), ALL, CML, MPS (myeloproliferative syndrome)) and lymphoid malignancies excluding ALL (23.8%; MM (multiple myeloma), NHL (nonHodgkin's lymphoma), CLL). Most patients (90.5%) received reduced-intensity regimens 42 and PBSC were used for the graft in all transplantations with a volunteer unrelated donor in 76.2%. Advanced disease was diagnosed in 65.7% of the patients at transplantation.
Mean time between day of admission and alloHCT was 11.6 ± 6.7 days, day þ 30 was 28.6 ± 2.9 days and day þ 100 was 99.4±6.5 days after alloHCT. By day þ 30, four patients had dropped out, as did another 13 patients by day þ 100 due to death or poor general condition. We had no data from day þ 30 and day þ 100 from seven and three patients, respectively, mainly because of early discharge. For longitudinal analysis and linear regression model, we had complete data from 78 patients.
Baseline nutritional status Different aspects of baseline nutritional status are shown in Figure 1 . At admission, most (77.1%) of the patients were classified as well nourished and few (9.5%) as severely malnourished according to the SGA questionnaire. However, 23.8% of the patients reported significant weight loss during the last 6 months of 5-10% (10.5%) and 410% (13.3%), respectively. Mean BMI was 25.9 ± 4.1 (16.5-35 .0) kg/m 2 and according to the WHO 43 1.9% and 54.3% were classified as underweight (p18.5 kg/m 2 ) and overweight (X25 kg/m 2 ), respectively. In contrast, abnormal ageand sex-adjusted BMI values (o10th, 490th percentiles) were found in 31.5%, with 22.9% having low and 8.6% high values. An overall low phase angle was detected in this study population with a mean SPA of À 1.31 ± 1.25. The probability of having positive SPA values, and phase angle values above age-, genderand BMI-specific reference values, was unexpectedly low (13.3%) in this cohort.
Course of nutritional status Longitudinal data (N ¼ 78 patients) of weight, represented as BMI, and of SPA are shown in Figure 2 , revealing that BMI decreased significantly (Po0.0001) in both measured periods from 26.1±3.8 kg/m 2 at admission to 23.2±3.0 kg/m 2 at day þ 100 by 11% in total. In other words, this represents a total weight loss of 8.6 ± 5.7 kg during the study period. Simultaneously, the patients experienced an extraordinarily high 74.3% drop in the SPA during the first 40 days after admission (Po0.0001). We observed a trend towards further SPA deterioration during the rehabilitation period after ward discharge till day þ 100 (P ¼ 0.06). Upon closer inspection of the significant weight loss with bioelectrical impedance analysis, one notes that the BMI reduction until day þ 30 was based on significant losses (Po0.0001) of both body fat mass and fat-free mass indices by B7% each. Thereafter, only the significant (11%) loss of body fat mass index was responsible for the ongoing loss of body weight after ward discharge till day þ 100 (Po0.0001).
Impact of factors influencing the body weight course As body weight loss remains significant during the rehabilitation period after ward discharge, we investigated the impact of a variety of potential influencing factors of body weight. We used change in BMI, weight normalized for height, as the dependent variable. All the influencing factors for univariate analysis we considered are listed in Table 2 . In univariate analysis, only clinically relevant aGVHD (P ¼ 0.02) and unrelated donor status (P ¼ 0.047) were significantly associated with increased loss of BMI. A multivariate regression model was constructed with those variables showing a relationship (Po0.1) to BMI course. Anorexia, HCT-CI and BMI on day þ 30 were added in this model and after multivariable adjustment, clinically relevant aGVHD (XII) (parameter estimate 1.43; 95% CI: À 2.61, À 0.26; P ¼ 0.02) and moderate/severe anorexia (XII) (parameter estimate 1.07; 95% CI: À 0.04, 2.18; P ¼ 0.058) were identified as independent influencing factors of BMI loss in the investigated period.
DISCUSSION
We herein present a longitudinal follow-up of nutritional status in adults undergoing alloHCT, and for the first time a multivariate linear regression model investigating the impact of factors on the course of body weight during the early rehabilitation period.
When adjusted BMI (78% in normal range) and the SGA questionnaire (77% well nourished) before alloHCT are considered, our findings on nutritional status in patients with hematological malignancies are consistent with other reports showing that the majority of these patients is well nourished. 
b To classify oral mucositis, we used the WHO oral toxicity scale, 26 which summarizes mucositis-related symptoms, signs and functional disturbances on a five-point global scale. Gradings: ¼ no, Classifications and results of weight change over the previous 6 months; age-and sex-adjusted BMI; SGA questionnaire and SPA are shown.
Course of nutritional status in alloHCT P Urbain et al approximately half of the patients experienced unintentional weight loss over the previous 6 months before alloHCT, revealing that changes in body composition were a frequent condition in these patients-a fact often overlooked when using BMI as the sole tool in the determination of nutritional status. According to the adjusted BMI classification, 10 times more patients were classified as underweight according to age-and gender-specific percentiles than when referring to the standard WHO classification. The WHO classification of, for example, normal weight (18.5-25 kg/m 2 ) does not consider the dynamic changes and gender-specific differences in body weight over the entire lifespan, 27 nor does it take into account that when considering allcause mortality, optimal BMI varies by age and sex. 47, 48 We therefore recommend that, when the BMI is used in the context of nutritional assessment, it should be employed to compare BMI calculations with age-and gender-specific BMI percentiles of an appropriate reference population.
Further, on closer inspection with bioelectrical impedance analysis measurements, we detected positive SPA values (expected in well-nourished, healthy individuals) in only 13.3% of our patients despite their overall normal BMI. This reveals that the phase angle, which is a valid nutritional marker and independent indicator of survival for patients receiving chemotherapy, 16, [18] [19] [20] 31 was extremely low in this cohort. Within this cohort, we also investigated the validity of these nutritional markers as risk factors for outcomes after alloHCT and found that the pre-transplant phase angle is an independent predictor for 2-year overall survival, relapse mortality and progression-free survival (Urbain, unpublished data). A reduced phase angle can be the result of or the combination of either body cell mass loss (especially muscle mass via prolonged physical inactivity), cell membrane weakness and increased body water displacement into extracellular space, 16, 49 which are the main characteristic changes triggered by malnutrition.
Explanations for this completely different picture provided by the phase angle compared with BMI and the SGA questionnaire are that BMI is a limited measure of nutritional status, giving us only information on low-or high-fat mass; the SGA questionnaire's main classification criterion is weight change over the previous weeks. A major limitation of these quick tools (BMI, SGA questionnaire) is that relevant changes in body composition (for example, loss of fat-free mass, mainly due to muscle atrophy) can be disguised by an increase in fat mass or fluid retention leading to stable overall weight, 50 which is highlighted by a small study in alloHCT patients showing significant fluid shifts to extracellular space, along with significant body cell mass loss till day þ 30, whereby body weight and fat mass remained constant. 51 This brings into focus the proposal that body composition measurements such as bioelectrical impedance analysis, muscular strength and/or mid-arm muscle circumference are indicated for the assessment of nutritional status in these patients.
Regarding changes in nutritional status during the early posttransplant period, we demonstrate convincingly that the losses of body weight and phase angle are especially high in the period between admission until day þ 30 (a 40-day interval), and that they do not cease during the 2 months of rehabilitation after hospital discharge, although we did notice that these deteriorations were somewhat alleviated. Weight loss during the early posttransplant period from day þ 30 until day þ 100 rose significantly due to the severity of anorexia and aGVHD XII, both predominant alloHCT-associated complications. [52] [53] [54] Depending on the organs affected by aGVHD (XII), it can alter nutritional status directly via food intake or nutrient uptake or indirectly via corticosteroid therapy, both of which have negative effects on muscle metabolism. 5 On closer examination, we found that weight loss resulted initially in loss of both fat-free mass and body fat mass compartments and after hospital discharge until day þ 100, mainly in the depletion of body fat mass. Loss of fat-free mass is one of the factors associated with muscle wasting, whereas the fat-free mass correlates better with functional parameters such as forced vital capacity, forced expiratory volume, 6 min walking test and mortality than BMI. 55, 56 Moreover, Lenssen et al. 9 reported Course of nutritional status in alloHCT P Urbain et al that the frequency of depleted muscle reserves rose independently of weight changes during the first post-transplant year in alloHCT recipients. Kyle et al. 11 even showed that any loss of weight and lean body mass experienced during the immediate post-transplant period (reflecting muscle mass among other factors) is not regained during the first year. Possible explanatory models include among others decline in physical activities for up to 1 year after transplantation, 9 a negative energy balance due to hypermetabolism, and the catabolic effects on skeletal muscle exerted by medication with corticosteroids 5, 6 as well as immunosuppressive drugs. 57, 58 A limitation of this study relates to the lack of an exact record of the duration and quantity of corticosteroid medication during the study period, which is known to promote muscle atrophy and should therefore be included in future regression models.
In conclusion, we found unintentional weight loss before alloHCT to be a frequent condition, many more underweight patients by using age-and gender-specific BMI classification, and overall low-phase angle values at admission. The deterioration in our cohort's nutritional status was significant during the early post-transplant period, despite of our clinic's internal standards of regular diet counseling, parenteral nutrition when needed and high energy supplements ad libitum, combined with regular mobilization and light physical activities. In addition, our results reveal the key role of more reliable methods with which to identify those patients who need individually adapted nutritional interventions and for monitoring the response to such treatments. Further studies are necessary to investigate new nutritional intervention strategies combined with physical training capable of preventing or reducing such deterioration in nutritional status, in particular fat-free mass loss during the early post-transplant period.
